Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Are patients with ulcerative colitis still at increased risk of colon cancer?

Damas OM, Abreu MT.

Lancet. 2020 Jan 11;395(10218):92-94. doi: 10.1016/S0140-6736(19)33225-8. No abstract available.

PMID:
31929018
2.

Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients.

Faye AS, Oh A, Kumble LD, Kiran RP, Wen T, Lawlor G, Lichtiger S, Abreu MT, Hur C.

Inflamm Bowel Dis. 2019 Dec 27. pii: izz307. doi: 10.1093/ibd/izz307. [Epub ahead of print]

PMID:
31880776
3.

Intestinal Epithelial Cells Respond to Chronic Inflammation and Dysbiosis by Synthesizing H2O2.

Burgueño JF, Fritsch J, Santander AM, Brito N, Fernández I, Pignac-Kobinger J, Conner GE, Abreu MT.

Front Physiol. 2019 Dec 12;10:1484. doi: 10.3389/fphys.2019.01484. eCollection 2019.

4.

Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition.

Fritsch J, Abreu MT.

Gastroenterology. 2020 Feb;158(3):470-472. doi: 10.1053/j.gastro.2019.11.303. Epub 2019 Dec 19. No abstract available.

PMID:
31863743
5.

Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis: Ustekinumab PK and exposure-response in UC.

Adedokun OJ, Xu Z, Marano C, O'Brien C, Szapary P, Zhang H, Johanns J, Leong RW, Hisamatsu T, van Assche G, Danese S, Abreu MT, Sands BE, Sandborn WJ.

Clin Gastroenterol Hepatol. 2019 Dec 6. pii: S1542-3565(19)31403-X. doi: 10.1016/j.cgh.2019.11.059. [Epub ahead of print]

6.

Combining Biologic Agents in Inflammatory Bowel Disease.

Abreu MT.

Gastroenterol Hepatol (N Y). 2019 Oct;15(10):549-551. No abstract available.

7.

Prescription opioid induce gut dysbiosis and exacerbate colitis in a murine model of Inflammatory Bowel Disease.

Sharma U, Olson RK, Erhart FN, Zhang L, Meng J, Segura B, Banerjee S, Sharma M, Saluja AK, Ramakrishnan S, Abreu MT, Roy S.

J Crohns Colitis. 2019 Nov 27. pii: jjz188. doi: 10.1093/ecco-jcc/jjz188. [Epub ahead of print]

PMID:
31773170
8.

Digging Deeper to Increase Understanding of Endoscopic and Histopathology Risk Factors for Progression of Dysplasia in Patients With Inflammatory Bowel Diseases.

Damas OM, Abreu MT.

Clin Gastroenterol Hepatol. 2019 Nov 18. pii: S1542-3565(19)31314-X. doi: 10.1016/j.cgh.2019.11.027. [Epub ahead of print] No abstract available.

PMID:
31751772
9.

Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.

Dheer R, Davies JM, Quintero MA, Damas OM, Deshpande AR, Kerman DH, Sawyer WP, Pignac-Kobinger J, Ban Y, Fernandez I, Burgueno JF, Phillips MC, Abreu MT.

Cell Mol Gastroenterol Hepatol. 2019 Nov 15;9(3):387-402. doi: 10.1016/j.jcmgh.2019.10.013. [Epub ahead of print]

10.

Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing.

Rezapour M, Quintero MA, Khakoo NS, Sussman DA, Barkin JA, Clarke J, Varma T, Deshpande AR, Kerman DH, Damas O, Abreu MT.

Crohns Colitis 360. 2019 Oct;1(3):otz033. doi: 10.1093/crocol/otz033. Epub 2019 Oct 15.

11.

DDS Perspective: My Take on Therapeutic Drug Monitoring in IBD.

Abreu MT.

Dig Dis Sci. 2019 Dec;64(12):3377-3381. doi: 10.1007/s10620-019-05796-z. No abstract available.

PMID:
31628571
12.

DDS Profile: Maria T. Abreu, MD.

Abreu MT.

Dig Dis Sci. 2019 Dec;64(12):3375-3376. doi: 10.1007/s10620-019-05795-0. No abstract available.

PMID:
31628570
13.

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.

Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group.

N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750.

PMID:
31553833
14.

Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome.

Zhang L, Meng J, Ban Y, Jalodia R, Chupikova I, Fernandez I, Brito N, Sharma U, Abreu MT, Ramakrishnan S, Roy S.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13523-13532. doi: 10.1073/pnas.1901182116. Epub 2019 Jun 17.

15.

The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?

Fritsch J, Abreu MT.

Gastrointest Endosc Clin N Am. 2019 Jul;29(3):381-393. doi: 10.1016/j.giec.2019.02.005. Epub 2019 Apr 5. Review.

PMID:
31078242
16.

Fluid supplementation accelerates epithelial repair during chemical colitis.

Burgueño JF, Lang JK, Santander AM, Fernández I, Fernández E, Zaias J, Abreu MT.

PLoS One. 2019 Apr 19;14(4):e0215387. doi: 10.1371/journal.pone.0215387. eCollection 2019.

17.

Diet as Adjunctive Treatment for Inflammatory Bowel Disease: Review and Update of the Latest Literature.

Damas OM, Garces L, Abreu MT.

Curr Treat Options Gastroenterol. 2019 Jun;17(2):313-325. doi: 10.1007/s11938-019-00231-8. Review.

18.

Updates in mucosal immunology for inflammatory bowel diseases.

Abreu MT.

Curr Opin Gastroenterol. 2018 Nov;34(6):375-376. doi: 10.1097/MOG.0000000000000484. No abstract available.

PMID:
30239344
19.

A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn's Disease.

Sandborn WJ, Abreu MT, Dubinsky MC.

Gastroenterol Hepatol (N Y). 2018 May;14(5 Suppl 2):1-12.

20.

Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease.

Damas OM, Estes D, Avalos D, Quintero MA, Morillo D, Caraballo F, Lopez J, Deshpande AR, Kerman D, McCauley JL, Palacio A, Abreu MT, Schwartz SJ.

Dig Dis Sci. 2018 Nov;63(11):3058-3066. doi: 10.1007/s10620-018-5185-2. Epub 2018 Jul 7.

21.

Investigation of Microbiota Alterations and Intestinal Inflammation Post-Spinal Cord Injury in Rat Model.

O'Connor G, Jeffrey E, Madorma D, Marcillo A, Abreu MT, Deo SK, Dietrich WD, Daunert S.

J Neurotrauma. 2018 Sep 15;35(18):2159-2166. doi: 10.1089/neu.2017.5349. Epub 2018 Jun 7.

22.

Inflammatory Cytokine Profile in Crohn's Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy.

Yarur AJ, Jain A, Quintero MA, Czul F, Deshpande AR, Kerman DH, Abreu MT.

J Clin Gastroenterol. 2019 Mar;53(3):210-215. doi: 10.1097/MCG.0000000000001002.

PMID:
29517712
23.

Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines.

Miska J, Lui JB, Toomer KH, Devarajan P, Cai X, Houghton J, Lopez DM, Abreu MT, Wang G, Chen Z.

J Exp Med. 2018 Mar 5;215(3):841-858. doi: 10.1084/jem.20171971. Epub 2018 Jan 26.

24.

The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids.

Cao W, Kayama H, Chen ML, Delmas A, Sun A, Kim SY, Rangarajan ES, McKevitt K, Beck AP, Jackson CB, Crynen G, Oikonomopoulos A, Lacey PN, Martinez GJ, Izard T, Lorenz RG, Rodriguez-Palacios A, Cominelli F, Abreu MT, Hommes DW, Koralov SB, Takeda K, Sundrud MS.

Immunity. 2017 Dec 19;47(6):1182-1196.e10. doi: 10.1016/j.immuni.2017.11.012.

25.

Intestinal exposure to PCB 153 induces inflammation via the ATM/NEMO pathway.

Phillips MC, Dheer R, Santaolalla R, Davies JM, Burgueño J, Lang JK, Toborek M, Abreu MT.

Toxicol Appl Pharmacol. 2018 Jan 15;339:24-33. doi: 10.1016/j.taap.2017.11.027. Epub 2017 Nov 29.

26.

Letter: Cuban immigrants to the US developing IBD have a progressive shortening of the lag between time of arrival and disease onset. Authors' reply.

Damas O, Abreu MT.

Aliment Pharmacol Ther. 2017 Oct;46(8):768-769. doi: 10.1111/apt.14278. No abstract available.

27.

Editorial: migration studies to determine risk and cause of inflammatory bowel disease-authors' reply.

Damas OM, Schwartz SJ, Abreu MT.

Aliment Pharmacol Ther. 2017 Aug;46(4):467. doi: 10.1111/apt.14200. No abstract available.

28.

Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.

Li B, Orton D, Neitzel LR, Astudillo L, Shen C, Long J, Chen X, Kirkbride KC, Doundoulakis T, Guerra ML, Zaias J, Fei DL, Rodriguez-Blanco J, Thorne C, Wang Z, Jin K, Nguyen DM, Sands LR, Marchetti F, Abreu MT, Cobb MH, Capobianco AJ, Lee E, Robbins DJ.

Sci Signal. 2017 Jun 27;10(485). pii: eaak9916. doi: 10.1126/scisignal.aak9916.

29.

Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba.

Damas OM, Avalos DJ, Palacio AM, Gomez L, Quintero MA, Deshpande AR, Sussman DA, McCauley JL, Lopez J, Schwartz SJ, Abreu MT.

Aliment Pharmacol Ther. 2017 Aug;46(3):303-309. doi: 10.1111/apt.14145. Epub 2017 May 19.

30.

Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction.

Gerassy-Vainberg S, Blatt A, Danin-Poleg Y, Gershovich K, Sabo E, Nevelsky A, Daniel S, Dahan A, Ziv O, Dheer R, Abreu MT, Koren O, Kashi Y, Chowers Y.

Gut. 2018 Jan;67(1):97-107. doi: 10.1136/gutjnl-2017-313789. Epub 2017 Apr 24.

PMID:
28438965
31.

Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort.

Damas OM, Gomez L, Quintero MA, Rampersaud E, Slifer S, Beecham GW, Kerman DH, Deshpande AR, Sussman DA, Abreu MT, McCauley JL.

Clin Transl Gastroenterol. 2017 Apr 13;8(4):e87. doi: 10.1038/ctg.2017.13.

32.

United States-Cuba Research Collaborations: Opening Bridges for Gastroenterology.

Abreu MT, Damas OM, Piñol Jiménez FN, Cañete Villafranca R.

Gastroenterology. 2017 May;152(6):1267-1269. doi: 10.1053/j.gastro.2017.03.011. Epub 2017 Mar 19. No abstract available.

PMID:
28327366
33.

Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.

Yarur AJ, Kanagala V, Stein DJ, Czul F, Quintero MA, Agrawal D, Patel A, Best K, Fox C, Idstein K, Abreu MT.

Aliment Pharmacol Ther. 2017 Apr;45(7):933-940. doi: 10.1111/apt.13970. Epub 2017 Feb 17.

34.

Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.

Yarur AJ, Quintero MA, Jain A, Czul F, Barkin JS, Abreu MT.

Inflamm Bowel Dis. 2017 Jan;23(1):158-164. doi: 10.1097/MIB.0000000000000991.

PMID:
27930409
35.

Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.

Lewis JD, Abreu MT.

Gastroenterology. 2017 Feb;152(2):398-414.e6. doi: 10.1053/j.gastro.2016.10.019. Epub 2016 Oct 25.

PMID:
27793606
36.

Endoscopy in Inflammatory Bowel Disease.

Abreu MT.

Gastrointest Endosc Clin N Am. 2016 Oct;26(4):xv-xvi. doi: 10.1016/j.giec.2016.07.001. No abstract available.

PMID:
27633602
37.

A Personalized Approach to Managing Inflammatory Bowel Disease.

Kingsley MJ, Abreu MT.

Gastroenterol Hepatol (N Y). 2016 May;12(5):308-15.

38.

A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.

Chuang LS, Villaverde N, Hui KY, Mortha A, Rahman A, Levine AP, Haritunians T, Evelyn Ng SM, Zhang W, Hsu NY, Facey JA, Luong T, Fernandez-Hernandez H, Li D, Rivas M, Schiff ER, Gusev A, Schumm LP, Bowen BM, Sharma Y, Ning K, Remark R, Gnjatic S, Legnani P, George J, Sands BE, Stempak JM, Datta LW, Lipka S, Katz S, Cheifetz AS, Barzilai N, Pontikos N, Abraham C, Dubinsky MJ, Targan S, Taylor K, Rotter JI, Scherl EJ, Desnick RJ, Abreu MT, Zhao H, Atzmon G, Pe'er I, Kugathasan S, Hakonarson H, McCauley JL, Lencz T, Darvasi A, Plagnol V, Silverberg MS, Muise AM, Brant SR, Daly MJ, Segal AW, Duerr RH, Merad M, McGovern DP, Peter I, Cho JH.

Gastroenterology. 2016 Oct;151(4):710-723.e2. doi: 10.1053/j.gastro.2016.06.045. Epub 2016 Jul 1.

39.

Diet and Inflammatory Bowel Disease.

Knight-Sepulveda K, Kais S, Santaolalla R, Abreu MT.

Gastroenterol Hepatol (N Y). 2015 Aug;11(8):511-20.

40.

Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency.

Berera S, Koru-Sengul T, Miao F, Carrasquillo O, Nadji M, Zhang Y, Hosein PJ, McCauley JL, Abreu MT, Sussman DA.

Clin Gastroenterol Hepatol. 2016 Aug;14(8):1163-71. doi: 10.1016/j.cgh.2016.03.037. Epub 2016 Apr 1.

PMID:
27046481
41.

Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer.

Davies JM, Santaolalla R, Abreu MT.

Inflamm Bowel Dis. 2016 Apr;22(4):976-83. doi: 10.1097/MIB.0000000000000756. Review.

42.

Intestinal Epithelial Toll-Like Receptor 4 Signaling Affects Epithelial Function and Colonic Microbiota and Promotes a Risk for Transmissible Colitis.

Dheer R, Santaolalla R, Davies JM, Lang JK, Phillips MC, Pastorini C, Vazquez-Pertejo MT, Abreu MT.

Infect Immun. 2016 Jan 11;84(3):798-810. doi: 10.1128/IAI.01374-15.

43.

Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis.

Yarur AJ, Jain A, Hauenstein SI, Quintero MA, Barkin JS, Deshpande AR, Sussman DA, Singh S, Abreu MT.

Inflamm Bowel Dis. 2016 Feb;22(2):409-15. doi: 10.1097/MIB.0000000000000689.

PMID:
26752470
44.

Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis.

Marion JF, Waye JD, Israel Y, Present DH, Suprun M, Bodian C, Harpaz N, Chapman M, Itzkowitz S, Abreu MT, Ullman TA, McBride RB, Aisenberg J, Mayer L; Chromoendoscopy Study Group at Mount Sinai School of Medicine.

Clin Gastroenterol Hepatol. 2016 May;14(5):713-9. doi: 10.1016/j.cgh.2015.11.011. Epub 2015 Dec 2.

PMID:
26656297
45.

Development of Advanced Imaging Criteria for the Endoscopic Identification of Inflammatory Polyps.

Sussman DA, Barkin JA, Martin AM, Varma T, Clarke J, Quintero MA, Barkin HB, Deshpande AR, Barkin JS, Abreu MT.

Clin Transl Gastroenterol. 2015 Nov 19;6:e128. doi: 10.1038/ctg.2015.51.

46.

Deciphering the genetic code of gastrointestinal diseases among African Americans.

Laiyemo AO, Abreu MT.

Gastroenterology. 2015 Nov;149(6):1323-6. doi: 10.1053/j.gastro.2015.09.029. Epub 2015 Sep 28. No abstract available.

47.

The Viral Mimetic Polyinosinic:Polycytidylic Acid Alters the Growth Characteristics of Small Intestinal and Colonic Crypt Cultures.

Davies JM, Santaolalla R, von Furstenberg RJ, Henning SJ, Abreu MT.

PLoS One. 2015 Sep 28;10(9):e0138531. doi: 10.1371/journal.pone.0138531. eCollection 2015.

48.

Treating Inflammatory Bowel Disease in Pregnancy: The Issues We Face Today.

Damas OM, Deshpande AR, Avalos DJ, Abreu MT.

J Crohns Colitis. 2015 Oct;9(10):928-36. doi: 10.1093/ecco-jcc/jjv118. Epub 2015 Jun 30. Review.

PMID:
26129693
49.

The impact of anesthesia providers on major morbidity following screening colonoscopies.

Lubarsky DA, Guercio JR, Hanna JW, Abreu MT, Ma Q, Uribe C, Birnbach DJ, Sinclair DR, Candiotti KA.

J Multidiscip Healthc. 2015 May 28;8:255-70. doi: 10.2147/JMDH.S77408. eCollection 2015.

50.

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

Travis SP, Schnell D, Feagan BG, Abreu MT, Altman DG, Hanauer SB, Krzeski P, Lichtenstein GR, Marteau PR, Mary JY, Reinisch W, Sands BE, Schnell P, Yacyshyn BR, Colombel JF, Bernhardt CA, Sandborn WJ.

J Crohns Colitis. 2015 Aug;9(8):607-16. doi: 10.1093/ecco-jcc/jjv077. Epub 2015 May 8.

Supplemental Content

Loading ...
Support Center